Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00758563 · ClinicalTrials.gov registry record · Phase 3

Train New Examiners Via Modified Gingival Margin Plaque

A Phase 3 study, sponsored by Colgate Palmolive.

Completed
Registry status
Phase 3
Development phase
15
Enrollment target

NCT00758563: Completed Phase 3 study, sponsored by Colgate Palmolive.

NCT00758563 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 15 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00758563, a Phase 3 study, has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
Phase 3
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to train new examiners while testing two commercial products using our standard one-day brushing study regimen by measuring gingival margin plaque index.

Primary Outcome

Scale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque).

Interventions

  • DRUG Fluoride
  • DRUG Triclosan/Fluoride

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2008-03
Est. Completion 2008-04
Phase Phase 3
Colgate Palmolive

51 total trials

What the finished NCT00758563 record still lists

NCT00758563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Fluoride is the first listed.

NCT00758563 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00758563 about?

NCT00758563 is a clinical study titled "Train New Examiners Via Modified Gingival Margin Plaque". The purpose of this study is to train new examiners while testing two commercial products using our standard one-day brushing study regimen by measuring gingival margin plaque index.

What is the current status of trial NCT00758563?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 15 participants. The study started on 2008-03. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00758563?

The interventions under investigation include: Fluoride (DRUG), Triclosan/Fluoride (DRUG).

Who is sponsoring clinical trial NCT00758563?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00758563's enrollment target sits among peer trials

15 1977th of 2000 higher than 18 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00758563, the US trial registry maintained by the National Library of Medicine. NCT00758563 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.